Grand Rounds convenes pathfinding academics, VCs, pharmas and biotechs to discuss critical issues in translation
NASHVILLE, Tenn.--(BUSINESS WIRE)--#BioCenturyGrandRounds--Thought leaders from academia, industry and venture capital will join the launch of BioCentury Grand Rounds next month – a conference that brings biopharma R&D decision-makers, academic innovators and early-stage investors together to discuss critical bottlenecks in the translation of scientific discoveries into the next wave of biotech breakthroughs.
More than 70 KOLs will join the program Sept. 9-11 at the Four Seasons Hotel Nashville, including an opening plenary with the heads of research from Biogen Inc. and Novartis AG. View the full agenda.
The conference will focus on four Hot Topic themes:
- Translational Bottlenecks
- Modality Groundbreakers
- The Human Data Revolution
- The Disease Biology Boom
"Grand Rounds is the newest link in our chain of global biopharma events and our first pure R&D showcase," said David Flores, President & CEO of BioCentury. "We picked Nashville to demonstrate that innovation flourishes everywhere." Flores co-founded BioCentury with Chairman Karen Bernstein in 1992.
"Bringing together leading and emerging innovators from all parts of the U.S. and beyond is core to our mission to advance the creation of medicines and build a global biotech ecosystem," said Simone Fishburn, VP & Editor in Chief of BioCentury. "We are so excited to add a key link in the chain and connect the critical thinkers who can help solve biopharma R&D's biggest challenges in translation."
The importance of this first BioCentury Grand Rounds in Nashville is demonstrated by its collaborators. Insights Partner McKinsey & Company is joined by Founding Investors 5AM Ventures, Arch Venture Partners, Deerfield Management, F2 Venture Capital, Iaso Ventures, Lightspeed Venture Partners, MPM BioImpact, Pappas Capital, Playground Global, Sofinnova Partners, SV Health Investors, Syncona, Third Rock Ventures and Xontogeny and Founding Sponsors Ipsos, Korea Drug Development Fund, Labcorp, Leerink Partners, NashBio and Nutter McClennen & Fish LLP.
Register. See the agenda. See the amazing speakers. Become a Sponsor. Become a Presenting Company. Join the poster presentations.
Find out more: Please visit , download the conference brochure or email Brian Denker at conferences@biocentury.com.
Contacts
Brian Denker
conferences@biocentury.com
